Two medications currently dominating the market are semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
Ideal anti-diabetic treatments on the view of NASH treatment must have weight-reducing efficacy, reduced cardiovascular event, prevention of HCC, low cost, and improved QOL [34]
Through its conduct on the GLP- 1 and GIP receptors, it helps suppress appetite and reduce food input, leading to conspicuous reductions in body weight
The histological benefit is large enough to have changed the regulatory landscape
Common Side Effects Side effects include flu-like symptoms, joint pain, hot flashes, headache, bronchitis, and swelling in arms or legs
Women appear to be at higher risk than men